MMP9 and cancer: Regarding this, Hsu et al. showed that 17β-estradiol treatment decreased MMP-2 and MMP-9 expression and cell mobility of human LoVo cancer cells by suppressing the activation of JNK1/2 and p38α MAPK signaling pathways [106,118].